Literature DB >> 22013971

OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Megan Roth1, Amanda Obaidat, Bruno Hagenbuch.   

Abstract

The human organic anion and cation transporters are classified within two SLC superfamilies. Superfamily SLCO (formerly SLC21A) consists of organic anion transporting polypeptides (OATPs), while the organic anion transporters (OATs) and the organic cation transporters (OCTs) are classified in the SLC22A superfamily. Individual members of each superfamily are expressed in essentially every epithelium throughout the body, where they play a significant role in drug absorption, distribution and elimination. Substrates of OATPs are mainly large hydrophobic organic anions, while OATs transport smaller and more hydrophilic organic anions and OCTs transport organic cations. In addition to endogenous substrates, such as steroids, hormones and neurotransmitters, numerous drugs and other xenobiotics are transported by these proteins, including statins, antivirals, antibiotics and anticancer drugs. Expression of OATPs, OATs and OCTs can be regulated at the protein or transcriptional level and appears to vary within each family by both protein and tissue type. All three superfamilies consist of 12 transmembrane domain proteins that have intracellular termini. Although no crystal structures have yet been determined, combinations of homology modelling and mutation experiments have been used to explore the mechanism of substrate recognition and transport. Several polymorphisms identified in members of these superfamilies have been shown to affect pharmacokinetics of their drug substrates, confirming the importance of these drug transporters for efficient pharmacological therapy. This review, unlike other reviews that focus on a single transporter family, briefly summarizes the current knowledge of all the functionally characterized human organic anion and cation drug uptake transporters of the SLCO and the SLC22A superfamilies.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22013971      PMCID: PMC3372714          DOI: 10.1111/j.1476-5381.2011.01724.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  304 in total

1.  Multispecific amphipathic substrate transport by an organic anion transporter of human liver.

Authors:  X Bossuyt; M Müller; P J Meier
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 2.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

3.  Comparative pharmacophore modeling of organic anion transporting polypeptides: a meta-analysis of rat Oatp1a1 and human OATP1B1.

Authors:  Cheng Chang; K Sandy Pang; Peter W Swaan; Sean Ekins
Journal:  J Pharmacol Exp Ther       Date:  2005-04-21       Impact factor: 4.030

4.  Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects.

Authors:  P L M van Giersbergen; A Treiber; R Schneiter; H Dietrich; J Dingemanse
Journal:  Clin Pharmacol Ther       Date:  2007-01-24       Impact factor: 6.875

5.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

6.  pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.

Authors:  Manthena V Varma; Charles J Rotter; Jonathan Chupka; Kevin M Whalen; David B Duignan; Bo Feng; John Litchfield; Theunis C Goosen; Ayman F El-Kattan
Journal:  Mol Pharm       Date:  2011-07-11       Impact factor: 4.939

7.  A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport.

Authors:  Jennifer L Perry; Neetu Dembla-Rajpal; Laura A Hall; John B Pritchard
Journal:  J Biol Chem       Date:  2006-10-11       Impact factor: 5.157

8.  Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants.

Authors:  Ilaria Badagnani; Richard A Castro; Travis R Taylor; Claire M Brett; Conrad C Huang; Douglas Stryke; Michiko Kawamoto; Susan J Johns; Thomas E Ferrin; Elaine J Carlson; Esteban G Burchard; Kathleen M Giacomini
Journal:  J Pharmacol Exp Ther       Date:  2006-05-15       Impact factor: 4.030

9.  Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.

Authors:  Hiroki Satoh; Fumiaki Yamashita; Masayuki Tsujimoto; Hideyasu Murakami; Noriko Koyabu; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Drug Metab Dispos       Date:  2005-01-07       Impact factor: 3.922

10.  Molecular characterization of human and rat organic anion transporter OATP-D.

Authors:  Hisanobu Adachi; Takehiro Suzuki; Michiaki Abe; Naoki Asano; Hiroya Mizutamari; Masayuki Tanemoto; Toshiyuki Nishio; Tohru Onogawa; Takafumi Toyohara; Satoshi Kasai; Fumitoshi Satoh; Masanori Suzuki; Taro Tokui; Michiaki Unno; Tooru Shimosegawa; Seiki Matsuno; Sadayoshi Ito; Takaaki Abe
Journal:  Am J Physiol Renal Physiol       Date:  2003-12
View more
  221 in total

1.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

2.  Transporters are an under-developed therapeutic target. Discuss.

Authors:  Steve Alexander
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

3.  To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.

Authors:  Sieto Bosgra; Maria L H Vlaming; Wouter H J Vaes
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

4.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

Authors:  Xiaoxi Lu; Ting Chan; Chenghao Xu; Ling Zhu; Qi Tony Zhou; Kade D Roberts; Hak-Kim Chan; Jian Li; Fanfan Zhou
Journal:  J Antimicrob Chemother       Date:  2015-10-22       Impact factor: 5.790

Review 5.  Understanding transport by the major facilitator superfamily (MFS): structures pave the way.

Authors:  Esben M Quistgaard; Christian Löw; Fatma Guettou; Pär Nordlund
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-13       Impact factor: 94.444

6.  Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.

Authors:  Derek Reichel; Bien Sagong; James Teh; Yi Zhang; Shawn Wagner; Hongqiang Wang; Leland W K Chung; Pramod Butte; Keith L Black; John S Yu; J Manuel Perez
Journal:  ACS Nano       Date:  2020-06-23       Impact factor: 15.881

7.  Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets.

Authors:  Jianan Tian; Mark P Keller; Angie T Oler; Mary E Rabaglia; Kathryn L Schueler; Donald S Stapleton; Aimee Teo Broman; Wen Zhao; Christina Kendziorski; Brian S Yandell; Bruno Hagenbuch; Karl W Broman; Alan D Attie
Journal:  Genetics       Date:  2015-09-18       Impact factor: 4.562

8.  Comparative bioinformatics, temporal and spatial expression analyses of Ixodes scapularis organic anion transporting polypeptides.

Authors:  Zeljko Radulović; Lindsay M Porter; Tae K Kim; Albert Mulenga
Journal:  Ticks Tick Borne Dis       Date:  2014-02-25       Impact factor: 3.744

9.  Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.

Authors:  Yuchen Zhang; Amanda Hays; Alexander Noblett; Mahendra Thapa; Duy H Hua; Bruno Hagenbuch
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

Review 10.  Placental control of drug delivery.

Authors:  Sanaalarab Al-Enazy; Shariq Ali; Norah Albekairi; Marwa El-Tawil; Erik Rytting
Journal:  Adv Drug Deliv Rev       Date:  2016-08-12       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.